Today, DigitalHealth.London has opened applications for the eighth cohort of their award-winning Accelerator programme, designed for digital health companies with innovative products or services that have a high potential to address current NHS and social care challenges. The programme helps innovators maximise their ability to engage commercially with the NHS and social care through enhanced connections, credibility, and confidence-building opportunities. Companies accepted into the DigitalHealth.London Accelerator benefit from: Tailored support from an assigned NHS Navigator with NHS clini ..read more

Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, we are excited to feature our current DigitalHealth.London Accelerator company Healthy.io and their digital wound management solution, Minuteful for Wound. What is the problem you are trying to solve and why is it important? Chronic wound management is a greater burden to the NHS than obesity and smoking-related illness, in 2017/2018 the cost of managing wounds was estimated to be £8.3 billion, that figure is now believed to cost closer to £10 billion. The caseload of 3.8 million peo ..read more

Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, we are excited to feature our current DigitalHealth.London Accelerator company Fruit Street. What is the problem you are trying to solve and why is it important? Prediabetes affects one in three adults, posing a significant risk for the onset of Type 2 diabetes. In the UK, Type 2 diabetes accounts for over 90% of all diabetes cases, resulting in increased healthcare expenses and potential health complications (i.e., heart disease, stroke, amputation, blindness, and dialysis). What is ..read more

Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, to commemorate World Liver Day, we are excited to feature our current DigitalHealth.London Accelerator company CyberLiver. What is the problem you are trying to solve and why is it important? Liver disease has seen mortality rates quadruple in the last forty years. Costing the healthcare sector £3 billion, the situation is exacerbated by alcohol abuse in the UK, which results in one million hospitalisations yearly and £21 billion in societal costs. By 2030, liver disease is expected ..read more

As innovations in FemTech continue to evolve, the future of women’s health holds promise for improved equity and accessibility. In this blog, Lavinia Pamparau, NHS Navigator for DigitalHealth.London, delves into how FemTech solutions tackle prevailing health disparities and empower women to proactively manage their health and well-being. Stemming from a historical lack of representation in medical research and gender bias, the absence of women-specific healthcare solutions has long been compounded by socioeconomic factors, ethnicity and geographic disparities. In particular, women from diverse ..read more

FemTech has the potential to tackle health inequalities related to gender and improve the quality of life for millions of women in the UK. But, to achieve maximum impact, FemTech needs to be fully integrated into NHS pathways and services. In this blog, NHS Navigator for DigitalHealth.London Yasmin Stinchcombe explores how FemTech innovators can successfully engage with the NHS. FemTech (female technology) is a category of health technology and services focused on supporting and improving women’s health. FemTech comprises numerous solutions and innovations designed for women’s health needs, in ..read more

Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, we are excited to feature Shahnawaz Asif Raja, who is currently participating in the DigitalHealth.London Leap programme. What was your motivation for founding your own company? My motivation for founding Biospiel stems from a lifelong aspiration to contribute to societal betterment through technology. Having grown up in Pakistan and pursued education across multiple countries, including Germany and Switzerland, I have witnessed firsthand the transformative power of innovation. This ..read more

In 2019, the Faculty of Business and Social Sciences at Kingston University Business School conducted research on Technology Foresight (TF), a strategic method employed by large multinational companies to guide their technology innovation planning. The research involved participation from several DigitalHealth.London Accelerator companies, facilitated by support and funding from the BEIS Business Basics Programme, Innovate UK, and the Innovation Growth Lab at Nesta. This study culminated in the publication of “Innovation and Foresight in SMEs: Lessons From the Case of U.K. Digital Health Compa ..read more

DigitalHealth.London alumni and current companies Cognitant, Dr Julian, Islacare, Surgery Hero, and Kidney Beam have been selected for the 2024 NHS Innovation Accelerator (NIA) cohort. Launched in 2015, the NIA is commissioned by the Accelerated Access Collaborative at NHS England, is delivered in partnership with all 15 Health Innovation Networks and hosted by UCLPartners. The NHS Innovation Accelerator (NIA) is a three-year programme championing innovation and business growth within the health and care sector. With a core focus on enhancing patient care, improving NHS efficacy, and fosterin ..read more

Today, DigitalHealth.London welcomes 16 digital health companies into Cohort 2 of its Evidence Generator Bootcamp. The companies chosen for the programme have products or services with high potential to meet NHS and/or social care challenges, that are committed to driving their evidence generation forward. The DigitalHealth.London Evidence Generator Bootcamp programme provides companies with 12 weeks of expert support from the NHS, academia and industry, advisory sessions and workshops, peer networking and honest brokering to foster research collaborations. It is part of the Digital Health.Lo ..read more